Edwards Lifesciences Corporation (EW) Q4 2022 Earnings Results

Edwards Lifesciences Beats on EPS, Stock Up 0.84%

Edwards Lifesciences reported an EPS of $0.64, beating expectations slightly. The stock reacted positively, rising by 0.84%. However, there was no revenue figure provided or additional guidance, leaving some uncertainty about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.64	N/A	+5.61%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

Edwards Lifesciences Beats on EPS, Stock Up 0.84%

Key numbers

Management commentary

Edwards Lifesciences Corporation

More earnings this week

Edwards Lifesciences Beats on EPS, Stock Up 0.84%

Key numbers

Management commentary